The gross law firm reminds regeneron pharmaceuticals, inc. investors of the pending class action lawsuit with a lead plaintiff deadline of march 10, 2025 - regn

New york , jan. 30, 2025 /prnewswire/ -- the gross law firm issues the following notice to shareholders of regeneron pharmaceuticals, inc. (nasdaq: regn). shareholders who purchased shares of regn during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
REGN Ratings Summary
REGN Quant Ranking